London, 9 November 2017, Consilium Strategic Communications, a global leader in strategic healthcare communications, is proud to sponsor the Alliance for Regenerative Medicine’s Fifth Annual European Advanced Therapies Investor Day, taking place today at 30 Euston Square Place, London.
This one-day, invitation-only meeting provides institutional, corporate, and private investors with exclusive access to this dynamic sector, offering unique, investment-driven insights into the state of clinical and commercial progress and development for advanced therapy medicinal products (ATMP).
The program will aim to address specific questions regarding the outlook for advanced therapies as well as offer insight into how these technologies could impact the standard of care in key therapeutic areas. Attendees will also hear from life science investment experts and analysts covering the sector, as well as presentations by leading European and international advanced therapies companies.
Featured Consilium clients include:
- Kiadis Pharma
- Oxford BioMedica
- Syncona
- TiGenix
The full programme can be viewed on the Alliance for Regenerative Medicine’s website: http://eu.arminvestorday.com/agenda/
